Stock Price
0.71
Daily Change
-0.05 -6.00%
Monthly
53.26%
Yearly
650.00%
Q2 Forecast
0.71

Starpharma Holdings reported AUD10.83M in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Medical Developments International AUD 21.57M 12.04M Dec/2025
Mesoblast USD 30.3M 17.1M Dec/2025
Neuren Pharmaceuticals AUD 42.24M 28.1M Dec/2025